LOGIN  |  REGISTER

CareCloud Solutions Will Help Transform Healthcare Operations for Phoenix Family Medical Clinic

May 03, 2023 | Last Trade: US$2.36 0.10 -4.07

SOMERSET, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced a new partnership with Phoenix Family Medical Clinic that will offer technology-enabled revenue cycle management (RCM) services and an integrated electronic health record (EHR) solution, chronic care management (CCM), and remote patient monitoring (RPM) to the Arizona-based clinic.

Phoenix Family Medical Clinic has chosen CareCloud's cutting-edge RCM solution, Concierge, to optimize their revenue and streamline administrative processes. By automating manual tasks like claims submission and follow-up, Concierge accelerates reimbursement and minimizes the potential for errors. In addition to Concierge, Phoenix will implement CareCloud Charts, an EHR platform that offers a comprehensive solution for managing patient data, including lab results, medication lists, and treatment plans. Charts facilitates seamless access and sharing of patient information, enhancing collaboration and coordination of care among healthcare providers. Phoenix will also use CareCloud Wellness, a suite of tools that include CCM and RPM. This combination will enable the clinic to efficiently manage complex care requirements for patients with chronic conditions. By remotely monitoring patients and intervening as needed, healthcare providers can minimize the risk of complications and hospitalizations and enhance patient outcomes.

These integrable solutions can completely transform operations for Phoenix Family Medical Clinic, also known as Whispering Palms, which has three locations in and around the Phoenix area serving a diverse population, including uninsured patients.

"We chose CareCloud because we needed a modern, cloud-based EHR and patient scheduling software that would enable us to provide better patient care while also improving our billing processes,” said Shallu Vaid, practice administrator at Phoenix Family Medical Center. “CareCloud's comprehensive scheduling system, e-prescribing, a patient portal, and lab integration are designed to make it easier for us to manage patient care and billing, while also improving the patient experience. With CareCloud, we have a partner we can trust to help us deliver high-quality care to our patients and thrive as a healthcare practice."

To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

Company Contact:
Bill Korn
Chief Financial Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page